WKN DE: A3DGS0 / ISIN: US29337E1029

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Enliven Therapeutics Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)
21:59:01	19,950	49
21:59:01	19,950	100
21:59:01	19,940	4
21:59:01	19,940	200
21:59:01	19,940	4
21:58:52	19,950	2
21:58:52	19,950	2
21:58:52	19,950	2
21:58:52	19,950	100
21:58:52	19,950	2
21:58:52	19,950	8
21:58:52	19,950	41
21:58:44	19,950	200
21:58:44	19,950	8
21:58:44	19,950	100
21:58:42	19,950	100
21:58:42	19,950	2
21:58:42	19,950	2
21:58:42	19,950	3
21:58:42	19,950	113
21:58:42	19,950	57
21:58:42	19,950	43
21:58:42	19,950	13
21:58:42	19,950	66
21:58:42	19,950	34
21:58:42	19,950	2
21:58:42	19,950	13
21:58:42	19,950	60
21:58:42	19,950	1
21:58:42	19,950	2
21:58:42	19,950	10
21:58:42	19,950	100
21:58:42	19,950	2
21:58:42	19,950	45
21:58:42	19,950	100

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Enliven Therapeutics Inc Registered Shs

Weitere Meldungen

18:33		Nike Just Did It—Turned $1.5 Billion Pain Into Performance
18:30		If You Invested $100 In Franco-Nevada Stock 10 Years Ago, You Would Have This Much Today
18:30		Why Reddit Stock Tumbled This Week
18:29		Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday
18:28		Why Did AngioDynamics Stock Pop Today?
18:26		Nvidia Becomes The $4.5 Trillion Giant Driving AI's Biggest Deals
18:22		AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
18:15		Here's How Much You Would Have Made Owning Wheaton Precious Metals Stock In The Last 20 Years
18:12		Microsoft 365: Neue Abostufe für Privatnutzer
18:09		How Coty ended up as Big Beauty’s ugly duckling
18:04		These high-quality stocks are helping this large-cap Janus mutual fund beat its peers
18:01		Looking At Roblox's Recent Unusual Options Activity
18:01		What Does the Market Think About Netflix Inc?
18:00		A Look Into Pfizer Inc's Price Over Earnings
18:00		Peering Into Hyatt Hotels Corp's Recent Short Interest
18:00		$100 Invested In TD Synnex 15 Years Ago Would Be Worth This Much Today
18:00		What's Fueling The Momentum In AngioDynamics Stock?
18:00		It’s a Bad Time to Cut the Information Coming From Corporate America
18:00		Europa League Soccer: Livestream Feyenoord vs. Aston Villa Live From Anywhere
18:00		Which Apple Watch Should You Buy? Apple Watch Series 11, Ultra 3 and SE 3 Compared
18:00		OpenAI joins an elite club with its new $500 billion valuation. Now comes the hard part.
17:53		OpenAI's Stargate Massive Memory Deal With Koreans Sparks More Frenzy In AI Trade And Overshadows Government Shutdown
17:52		Can Roku Stock Stay Above $100 This Time?
17:45		Here's How Much $1000 Invested In Eaton Corp 5 Years Ago Would Be Worth Today
17:44		What's Going On With Fair Issac (FICO) Shares Thursday?
17:37		Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
17:31		$100 Invested In Liberty Media 10 Years Ago Would Be Worth This Much Today
17:30		Why D-Wave Quantum Stock Keeps Going Up
17:22		What's Going On With QuantumScape (QS) Stock Today?
17:20		Why Dogecoin Is Rising Today
17:20		Nebius Stock Is Rising Thursday: What's Going On?
17:15		If You Invested $1000 In TE Connectivity Stock 15 Years Ago, You Would Have This Much Today
17:11		Occidental Petroleum (OXY) Shares Are Trading Lower Thursday: What's Going On?
17:10		Nike Analyst Turns Bullish On 'Win Now' Strategy, Margin Recovery
17:07		Delta Teams Up With Trackonomy To Speed Up Airport Cargo Handling
17:07		Norovirus Outbreak Sickens Nearly 100 on Royal Caribbean Cruise
17:05		These iPhone Settings Helped Me Cut Down on Screen Time
17:04		Credit bureaus snubbed in ‘Fico’ plan to sell mortgage scores direct to users
17:02		Tesla sales surge to record on rush to snag US tax credit
17:01		This Is What Whales Are Betting On Agnico Eagle Mines
17:01		How Is The Market Feeling About Texas Roadhouse Inc?
17:01		In-Depth Analysis: Apple Versus Competitors In Technology Hardware, Storage & Peripherals Industry
17:01		What's Driving the Market Sentiment Around Ares Capital Corp?
17:00		Exploring The Competitive Space: Amazon.com Versus Industry Peers In Broadline Retail
17:00		Peering Into Penumbra Inc's Recent Short Interest
17:00		Millions of Australians eligible for 5% first home buyers scheme may be unable to afford repayments
17:00		A Look Into Southwest Airlines Inc's Price Over Earnings
17:00		Industry Comparison: Evaluating Meta Platforms Against Competitors In Interactive Media & Services Industry
17:00		$100 Invested In Builders FirstSource 5 Years Ago Would Be Worth This Much Today
17:00		Competitor Analysis: Evaluating NVIDIA And Competitors In Semiconductors & Semiconductor Equipment Industry

Zurück | 1 | 2 | 3 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Aptorum Group Zoglo's Food Sheffield Resources Guizhou Zhenhua Fengguang Semiconductor a Lavoro

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	02.10.2025 23:22
Kaufwert:	EUR
	Hinzufügen Speichern

Enliven Therapeutics Aktie

WKN DE: A3DGS0 / ISIN: US29337E1029

Enliven Therapeutics Times and Sales (NAS)

Analysen zu Enliven Therapeutics Inc Registered Shs

Weitere Meldungen